Deroofing valuable dermatosurgical procedure for managing Hidradenitis suppurativa patients: Study

Written By : Aditi

Medically Reviewed By : Dr. Kamal Kant Kohli

Published On 2024-03-15 17:45 GMT | Update On 2024-03-16 03:46 GMT

Hidradenitis suppurativa (HS) is a chronic, recurrent and debilitating condition of the pilosebaceous unit. Despite advancements in the treatment of this condition, over 45% of patients express dissatisfaction following systemic treatments, while more than one-third are unsatisfied with surgical interventions.

According to an original investigation published in the Journal of The European Academy of Dermatology & Venereology,

researchers have concluded that Deroofing could be a safe, efficient, safe, and valuable dermatosurgical approach for managing HS patients. P. K. Krajewski et al. led this investigation.

Clinical assessments of HS lesions were done, and ultrasound was also used in the evaluation. Patients reported pain, itching, and satisfaction. These outcomes were measured 24 hours post-surgery using a numeric rating scale (NRS) ranging from 0 to 10. Researchers also evaluated the timeline of objective wound closure in weeks and the need for any analgesic use.

Key findings from the study are:

The mean closure time of the post-deroofing wound was assessed as 4.4 ± 1.9 weeks.
Complete closure took statistically longer in males than in females (4.9 ± 2.2 weeks and 3.9 ± 1.6 weeks, respectively).
The closure time was correlated positively yet weakly with the HS tunnel's width with r of 0.27 and 0.228 respectively.
Patients assessed mean pain as mild at 24 h post-operatively (0.7 ± 1.2 points according to NRS), and no differences between sexes were reported.
In the first 24 hours, itch was mild with 1.8 ± 1.1 points, without differences between sexes.
After a week of deroofing, no pain, itching or adverse events were reported.
Wound infections were not reported.
Patient satisfaction assessed as 9.9 ± 0.4 points.

In conclusion, they said, deroofing is an easy, effective, and safe dermatosurgical procedure. This intervention does not require surgical experience or operating theatre.

No complications were reported with the procedure. Postoperative pain was very low, they said.

Reference:

Krajewski, P., Sanz‐Motilva, V., Martinez, S. F., Solera, M., Ochando, G., Jfri, A., & Martorell, A. (2024). Deroofing: A safe, effective and well‐tolerated procedure in patients with hidradenitis suppurativa. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.19810

Article Source : Journal of The European Academy of Dermatology & Venereology,

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Aditi

Dr. Aditi Yadav is a BDS, MDS in Periodontics and Implantology. She has a clinical experience of 5 years as a laser dental surgeon. She also has a Diploma in clinical research and pharmacovigilance and is a Certified data scientist. She is currently working as a content developer in e-health services. Dr. Yadav has a keen interest in Medical Journalism and is actively involved in Medical Research writing.

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Deroofing valuable dermatosurgical procedure for managing Hidradenitis suppurativa patients: Study

Similar News

US FDA issued warning against manufacturers of mousse or whipped cream sunscreen products

Scientists Grow World's First Fully Functional Human Skin with Blood Supply

Low-Dose Oral Minoxidil for Hair Loss Not Linked to Tachycardia, Large Study Suggests

Atopic Dermatitis Linked to 27 Percent Higher Stroke Risk, Meta-Analysis Finds

Poor Heart-Kidney-Metabolic Health and Genetics May Double Psoriasis Risk, Study Finds

Lebrikizumab Shows Strong Efficacy and Safety in Atopic Dermatitis: Study

Dupilumab in Atopic Dermatitis Linked to Significant Weight Gain, Study Finds

Tildrakizumab Shows Significant Efficacy in Psoriatic Arthritis Phase 3 Trials